Regulating the Rate of Molecular Self-Assembly for Targeting Cancer Cells.
about
AIEgen-based theranostic system: targeted imaging of cancer cells and adjuvant amplification of antitumor efficacy of paclitaxelPeptide-drug conjugates as effective prodrug strategies for targeted delivery.Supramolecular biofunctional materials.Dual Fluorescent- and Isotopic-Labelled Self-Assembling Vancomycin for in vivo Imaging of Bacterial Infections.Non-equilibrium dissipative supramolecular materials with a tunable lifetime.In situ generated D-peptidic nanofibrils as multifaceted apoptotic inducers to target cancer cells.Sequentially Programmable and Cellularly Selective Assembly of Fluorescent Polymerized Vesicles for Monitoring Cell Apoptosis.Near-Infrared Fluorescent Molecular Probe for Sensitive Imaging of Keloid.Self-Assembling Ability Determines the Activity of Enzyme-Instructed Self-Assembly for Inhibiting Cancer Cells.Enzyme-instructed self-assembly with photo-responses for the photo-regulation of cancer cells.Enzymatic Self-Assembly Confers Exceptionally Strong Synergism with NF-κB Targeting for Selective Necroptosis of Cancer Cells.One-Component Supramolecular Filament Hydrogels as Theranostic Label-Free Magnetic Resonance Imaging Agents.Kinetic Analysis of Nanostructures Formed by Enzyme-Instructed Intracellular Assemblies against Cancer Cells.Selective inhibition of cancer cells by enzyme-induced gain of function of phosphorylated melittin analogues.Selectively Inducing Cancer Cell Death by Intracellular Enzyme-Instructed Self-Assembly (EISA) of Dipeptide Derivatives.Dual Fluorescent- and Isotopic-Labelled Self-Assembling Vancomycin for in vivo Imaging of Bacterial Infections
P2860
Q33609659-96522A26-0E41-411E-9600-26FEA8998CFAQ38883760-D6073365-272A-4567-830A-2432D0A6B5FAQ39188196-880DE981-34FB-4A28-8DBF-250BE8901B3CQ40357421-916BCD9F-1EF0-4AAB-A62C-AD29497A8ECEQ41077893-48830E51-4757-4297-AFC7-93B0509F064DQ42292369-F385A0B5-7D7B-4324-8B2D-C09FDD13A423Q47104303-DE565624-85BA-4D21-9498-31F42EBE80F3Q47189368-20ABFC3F-E04C-4310-8809-5E773C3ACB9FQ47678631-33387CD2-5E8C-4681-9325-6D1BDF28EA58Q47854158-EB5FE996-9FA3-4C33-9718-7A9DB39E550FQ48150331-E9EF3E92-C6D1-44A4-8796-F7DBC0D7DC94Q48363024-B3660576-D186-4ED9-B030-6C1D480A8C54Q51734043-2C38940D-D2B1-4C71-B061-CE3CB3B78120Q52641548-C0EDED81-6628-46BE-8BCD-8E0295CDA039Q52902179-30BA27FD-7DD3-4D27-88B4-17A7B899F8B4Q59279588-1F70F59A-751E-404A-B104-FDDF09DB1FB7
P2860
Regulating the Rate of Molecular Self-Assembly for Targeting Cancer Cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Regulating the Rate of Molecular Self-Assembly for Targeting Cancer Cells.
@en
Regulating the Rate of Molecular Self-Assembly for Targeting Cancer Cells.
@nl
type
label
Regulating the Rate of Molecular Self-Assembly for Targeting Cancer Cells.
@en
Regulating the Rate of Molecular Self-Assembly for Targeting Cancer Cells.
@nl
prefLabel
Regulating the Rate of Molecular Self-Assembly for Targeting Cancer Cells.
@en
Regulating the Rate of Molecular Self-Assembly for Targeting Cancer Cells.
@nl
P2860
P356
P1476
Regulating the Rate of Molecular Self-Assembly for Targeting Cancer Cells.
@en
P2093
P2860
P304
P356
10.1002/ANIE.201600753
P407
P50
P577
2016-04-08T00:00:00Z